Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Esophageal chemical burns as a risk factor for esophageal malignancies: in-silico analyses - experimental research. | Ann Med Surg (Lond) | 2024 | 39239040 | PubTator, text mining | PubMed |
| BUB1 induces AKT/mTOR pathway activity to promote EMT induction in human small cell lung cancer. | Sci Rep | 2024 | 39232038 | PubTator, text mining | PubMed |
| Surface-mutagenesis strategies to enable structural biology crystallization platforms. | Acta Crystallogr D Struct Biol | 2024 | 39207897 | PubTator, text mining | PubMed |
| Exploration of biomarkers for nursing physical examination early screening of multiple tumors. | Medicine (Baltimore) | 2024 | 39151523 | PubTator, text mining | PubMed |
| Hereditary Colorectal Cancer and Polyposis Syndromes Caused by Variants in Uncommon Genes. | Genes Chromosomes Cancer | 2024 | 39120161 | PubTator, text mining | PubMed |
| Baitouweng decoction suppresses growth of esophageal carcinoma cells through miR-495-3p/BUB1/STAT3 axis. | World J Gastrointest Oncol | 2024 | 39072160 | PubTator, text mining | PubMed |
| Overexpression of BubR1 Mitotic Checkpoint Protein Predicts Short Survival and Influences the Progression of Cholangiocarcinoma. | Biomedicines | 2024 | 39062183 | PubTator, text mining | PubMed |
| Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer. | Sci Rep | 2024 | 39048649 | PubTator, text mining | PubMed |
| Identification of Hub Genes for Psoriasis and Cancer by Bioinformatic Analysis. | Biomed Res Int | 2024 | 39045407 | PubTator, text mining | PubMed |
| BUB1b impairs chemotherapy sensitivity via resistance to ferroptosis in lung adenocarcinoma. | Cell Death Dis | 2024 | 39043653 | PubTator, text mining | PubMed |
| Identification of novel biomarkers and potential molecular targets for uterine cancer using network-based approach. | Pathol Res Pract | 2024 | 39029376 | PubTator, text mining | PubMed |
| BUB1 potentiates gastric cancer proliferation and metastasis by activating TRAF6/NF-κB/FGF18 through m6A modification. | Life Sci | 2024 | 39025206 | PubTator, text mining | PubMed |
| Design and evaluation of novel inhibitors for the treatment of clear cell renal cell carcinoma. | Bioorg Chem | 2024 | 39002511 | PubTator, text mining | PubMed |
| BUB1 Inhibition Sensitizes TNBC Cell Lines to Chemotherapy and Radiotherapy. | Biomolecules | 2024 | 38927028 | PubTator, text mining | PubMed |
| BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer. | J Exp Clin Cancer Res | 2024 | 38863037 | PubTator, text mining | PubMed |
| Kaempferol from Alpinia officinarum hance induces G2/M cell cycle arrest in hepatocellular carcinoma cells by regulating the ATM/CHEK2/KNL1 pathway. | J Ethnopharmacol | 2024 | 38857680 | PubTator, text mining | PubMed |
| Unraveling malignant phenotype of peritumoral tissue: transcriptomic insights into early-stage breast cancer. | Breast Cancer Res | 2024 | 38831458 | PubTator, text mining | PubMed |
| TIP60 acetylation of Bub1 regulates centromeric H2AT120 phosphorylation for faithful chromosome segregation. | Sci China Life Sci | 2024 | 38763998 | PubTator, text mining | PubMed |
| Modification of Seurat v4 for the Development of a Phase Assignment Tool Able to Distinguish between G2 and Mitotic Cells. | Int J Mol Sci | 2024 | 38731808 | PubTator, text mining | PubMed |
| BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapy. | bioRxiv | 2024 | 38712071 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=9